Review paper
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
Abstract
Recent advancements in cancer biology, microbiology, and bioengineering have spurred the development of engineered live biotherapeutics for targeted cancer therapy. In particular, natural tumor-targeting and probiotic bacteria have been engineered for controlled and sustained delivery of anticancer agents into the tumor microenvironment (TME). Here, we review the latest advancements in the development of engineered bacteria for cancer therapy...
Paper Details
Title
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
Published Date
Dec 8, 2020
Journal
Volume
7
Issue
5
Pages
447 - 464